written on 27.03.2014
Tags:
,

Baxter to spin off its $6B biopharma business in industry's latest split-up

TAGS: ,

The pharma split-up movement is spreading. Baxter International says it will spin off its biopharma business into a separate company, leaving its $9 billion medical products business to venture on under the Baxter name.

Latest Report